Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) in Elderly (More Than 60 Years) Patients With Diffuse Large B Cell Lymphoma After 4 Cycles of CHOP21-Rituximab (CHOP21-R) Therapy
Clinical trial NCT00850512 · COMPLETED
Trial details
- NCT number
- NCT00850512
- Sponsor
- University of Bologna
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.